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Abstract
Background: Increasing evidence suggests that diets high in polyunsaturated fatty acids (PUFA) confer health
benefits by improving insulin sensitivity and lipid metabolism in liver, muscle and adipose tissue.
Methods: The present study investigates metabolic responses in two different lines of mice either selected for
high body weight (DU6) leading to rapid obesity development, or selected for high treadmill performance (DUhTP)
leading to a lean phenotype. At 29 days of age the mice were fed standard chow (7.2% fat, 25.7% protein), or a
high-fat diet rich in n-3 PUFA (n-3 HFD, 27.7% fat, 19% protein) or a high-fat diet rich in n-6 PUFA (n-6 HFD, 27.7%
fat, 18.6% protein) for 8 weeks. The aim of the study was to determine the effect of these PUFA-rich high-fat diets
on the fatty acid profile and on the protein expression of key components of insulin signalling pathways.
Results: Plasma concentrations of leptin and insulin were higher in DU6 in comparison with DUhTP mice. The
high-fat diets stimulated a strong increase in leptin levels and body fat only in DU6 mice. Muscle and liver fatty
acid composition were clearly changed by dietary lipid composition. In both lines of mice n-3 HFD feeding
significantly reduced the hepatic insulin receptor b protein concentration which may explain decreased insulin
action in liver. In contrast, protein kinase C ζ expression increased strongly in abdominal fat of n-3 HFD fed DUhTP
mice, indicating enhanced insulin sensitivity in adipose tissue.
Conclusions: A diet high in n-3 PUFA may facilitate a shift from fuel deposition in liver to fuel storage as fat in
adipose tissue in mice. Tissue specific changes in insulin sensitivity may describe, at least in part, the health
improving properties of dietary n-3 PUFA. However, important genotype-diet interactions may explain why such
diets have little effect in some population groups.
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Background
Obesity has increased at an alarming rate over the past
few decades, affecting a large population worldwide.
Major medical complications including type 2 diabetes
and cardiovascular disease are clearly linked with obesity
and are increasing public health concerns [1,2]. The com-
plex pathogenesis of obesity and type 2 diabetes is
influenced by both genetic and environmental variables
[3]. One of the most important contributing factors of
obesity and associated metabolic complications is a diet
of high caloric density which promotes excessive body
weight gain [4]. The high saturated fat content of the
Western diet is considered to be at least in part responsi-
ble for the perturbations in energy regulation observed in
many obese individuals [1,4].
In addition to the total calorie intake from dietary fat,
mounting evidence suggests that the absolute and relative
intake of specific n-6 and n-3 long-chain polyunsaturated
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[5]. Furthermore, specific dietary lipids can individually
influence metabolic pathways, changing the plasma lipid
profile and gene expression [6-8]. Recent studies have
shown that increasing saturated fatty acids in an obeso-
genic high-fat diet (HFD) significantly impairs insulin
sensitivity in liver, skeletal muscle, heart muscle and adi-
pose tissue in rodents [9-15]. Furthermore, diets rich in
n-6 PUFA may promote abdominal obesity, possibly by
increasing sterol regulatory element binding protein 1c
(SREBP1c) in visceral adipose tissues of rats, thereby sti-
mulating lipogenic pathways [16]. Conversely, it has been
proposed that diets rich in n-3 PUFA had anti-obeso-
genic effects and lead to a decrease in fat deposition and
fasting serum triglyceride concentrations concomitant
with an increase in energy expenditure and fatty acid oxi-
dation in human and rodent studies [17,18]. Dietary
lipids are also known to influence tissue fatty acid com-
position which is linked with changes in tissue function.
For example, PUFA are important constituents of the
lipid bilayer, enhancing membrane fluidity of cells and
modifying cellular processes in rodents [19,20]. There-
fore, dietary fatty acids play important roles in the struc-
tural composition of cells as well as in the signalling
functions of specific cellular processes.
Obesity is also influenced by genetic factors. It is clear
that obesity runs in families and the pattern of inheri-
tance of obesity strongly suggests that the effect is poly-
genic, with each variant of many different genes making a
small contribution to the outcome [21,22]. However, the
strong environmental effects that are observed have led
to the notion that obesity is the result of an interaction
between a genetic predisposition and environmental
influences, although the specific biological nature of
these interactions requires further investigation. Mice
from long-term selection experiments offer unique mod-
els to examine the contributions of genetic factors in
determining specific dietary influences on metabolic reg-
ulation relevant to obesity development. Mice lines with
biologically distinct traits, of an “energy storage pheno-
type“, the high body weight line (DU6); and of an “energy
usage phenotype“, the high treadmill performance line
(DUhTP), were generated by long-term selection from a
common genetic pool of outbred mice [23-25]. The nat-
ure of the high body weight gain and obesity develop-
ment in DU6 mice is polygenic and appears to be linked
to several quantitative trait loci on distinct chromosomes
contributing to higher body weight, increased fat accu-
mulation and metabolic changes [25-27]. Although the
genetic basis of leanness in DUhTP mice has not been
established, their phenotypic characteristics include
lower body weight, reduced food intake and smaller fat
depots [23,24]. There is also expanding research evidence
that selection of muscle performance is commonly based
on multiple gene polymorphisms [28-30].
T h ea i mo ft h ep r e s e n ts t u d yw a st oi n v e s t i g a t et h e
fatty acid composition of tissues, and the metabolic
responses to high-fat diets rich in either n-3 or n-6 PUFA
in mice, with a known predisposition for high body
weight or leanness. The study also investigates whether
different metabolic responses may be linked to changes
in insulin signalling pathways in liver, muscle and
abdominal adipose tissue. Therefore, it is hypothesised
that mice selected for either high body weight or leanness
show different responses in lipid metabolism and altera-
tions in insulin effectiveness. To test this hypothesis, we
examined the effect of n-3 PUFA and n-6 PUFA rich
high-fat diets on body weight, fatty acid composition,
metabolic regulation and insulin signalling pathways in
liver, muscle and adipose tissue of mice selected for
either high body weight or for high running performance.
The work presented here advances our understanding of
the metabolic responses to high-fat diets rich in n-3 and
n-6 PUFA and whether changes in insulin action and/or
lipid metabolism in liver, muscle and adipose tissue may
be involved. Different genetic predispositions (e.g. for
leanness or obesity) could favour specific metabolic path-
ways in the down-stream effects on lipid or carbohydrate
metabolism and influence the health outcome.
Materials and methods
Animals
In total 60 male mice of two different selection lines and
three dietary treatments were included in this study. The
selection of mice was based on traits for either high body
weight or high endurance fitness and was performed at
the Leibniz Institute in Dummerstorf (DU lines). The
high body weight line (DU6) was selected for high body
w e i g h ta td a y4 2( 6w e e k s )o fl i f eo v e r1 2 8g e n e r a t i o n s
[25]. The high treadmill performance line (DUhTP) was
selected for high treadmill performance measured by a
computer-controlled treadmill at day 70 of life for 95
generations [23,24]. Thirty mice of each selected line
were subdivided in 3 feeding groups with 10 mice per
group. The isocaloric high-fat diets (HFD) were enriched
either with n-3 PUFA (27% fish oil, n-3/n-6 (quotient
6.2); n-3 HFD) or with n-6 PUFA (27% sunflower oil,
n-3/n-6 (quotient 0.0062); n-6 HFD). The control group
was fed with standard mice chow (Altromin, Lage Ger-
m a n y ;7 %f a t ;s t a n d a r dc h o w ) .T h ec o m p o s i t i o no ft h e
different diets is presented in Table 1. The control diet
had a higher crude protein content compared to the
high-fat diets. Each animal was kept individually in a
cage equipped with wooden shavings and with free access
to water. From birth until the 28
th day of life all animals
were fed with the standard chow diet. From the 29
th until
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th day, animals were either allocated to one of the
high-fat diets or were kept continuously on the standard
chow. All diets were provided ad libitum.B o d yw e i g h t
was recorded weekly until the end of the experiment.
Mean food intake was determined weekly for each ani-
mal. Daily food intake, food intake per g metabolic body
weight (bwt
0.75) and daily calorie intake per g bwt
0.75
were calculated for all experi m e n t a lg r o u p s .A l la n i m a l
procedures were approved by the local animal welfare
authority (Reg.-No. LALLF M-V/TSD/7221.3-2.1-011/06).
Tissue and blood sample collection
At the end of the study at day 87, the animals were killed
by cervical dislocation and trunk blood samples were col-
lected after decapitation. Liver, quadriceps femoris mus-
cle and abdominal adipose tissue were dissected
immediately and were weighed, snap frozen in liquid
nitrogen and stored at -80°C until analysis. Analyses were
performed within one year after sampling. EDTA blood
was centrifuged at 2750 g at 4°C for 5 minutes. Plasma
was removed, centrifuged again and stored at -20°C for
future analysis.
Plasma analyses
Plasma leptin was measured by a commercial sandwich-
type ELISA (DSL, Webster, Texas, U.S.A.). The sensitiv-
ity (minimum detection limit) was 0.3 ng/ml. The coeffi-
cient of intra-assay variation was 5.9%, the coefficient of
inter-assay variation was 7.2%. The plasma insulin levels
were measured by a commercial radioimmunoassay
(RIA) (sensitive rat RIA, Linco, St. Charles, Missouri,
U.S.A.). The coefficient of intra-assay variation was
5.5%, the coefficient of inter-assay variation was 8.6%.
Total cholesterol, free fatty acids and glucose concentra-
t i o n sw e r ea n a l y s e du s i n gaC O B A SM I R AC h e m i s t r y
Analyzer (Roche, Switzerland) and respective test kits.
Total cholesterol was determined by colorimetric mea-
surements with end point detection of cholesterol
oxidase, phenol, aminoantipyrin (CHOD-PAP) (Labor
und Technik Lehmann, Berlin, Germany). Free fatty
acids were determined by colorimetric and enzymatic
measurements (RANDOX, Crumlin, UK). Plasma glu-
cose was determined by colorimetric measurements of
glucose-oxidase, phenol, aminoantipyrin (GOD-PAP)
(Labor und Technik Lehmann, Berlin, Germany).
Determination of fatty acid composition
Samples of livers (0.4-0.6 g) and quadriceps femoris mus-
cles (0.04-0.07 g) were thawed at 4°C. After homogenisa-
tion (Ultra Turrax, IKA Staufen, Germany; T25, 3 ×
15 sec, 12,000 rpm) and adding C19:0 as an internal stan-
dard, the total lipids were extracted in duplicates with
chloroform/methanol (2:1, v/v) at room temperature. All
the solvents contained 0.005% (w/v) of t-butylhydroxyto-
luene in order to avoid oxidation of PUFA. The extrac-
tion mixture was stored at 5°C for 18 h in the dark and
subsequently washed with 0.02% aqueous CaCl2.T h e
organic phase was dried with Na2SO4 and K2CO3 (10:1,
wt/wt) and the solvent was subsequently removed under
nitrogen at room temperature. The lipid extracts were
re-dissolved in toluene and 3 mg (muscle) to 20 mg
(liver) was used for methyl ester preparation. Fatty acids
of liver and muscle were determined by gas chromatogra-
phy as previously described by Dance et al.[ 3 1 ] .D e l t a - 9
desaturase index was calculated by the following equation
((C14:1+C16:1+C18:1+C17:1)/(C14:1+C16:1+C18:1
+C17:1+C14:0+C16:0+C17:0+ C18:0)) × 100 = Δ9. This
index largely reflects desaturase activity.
Tissue sample preparation
Liver, quadriceps femoris muscle and abdominal adipose
tissue samples were homogenised in ice-cold RIPA lysis
buffer (Triton X-100, sodium dodecyl sulphate, sodium
chloride, Tris-HCl, deoxycholic acid, sodium orthovana-
date, and Complete Mini EDTA-free protease inhibitors
from Roche, Diagnostics) and stored at -80°C until ana-
lysis. Protein concentrations of the liver and muscle
homogenates were determined using a Bradford assay.
Western blotting was performed as described earlier
[32]. In short, SDS-PAGE was performed using 8%
separation gels. Proteins were transferred onto nitrocellu-
lose membranes by tank blotting, blocked with fat-free
milk (5%) overnight (or for 2 h at RT for protein kinase
Table 1 Composition of the standard chow and the
PUFA-rich high-fat diets
n-3
HFD
n-6
HFD
Standard
chow
Crude protein (%/DM) 19·0 18·6 25·7
Crude fat (%/DM) 27·4 27·7 7·2
Crude ash (%/DM) 5·1 5·0 8·1
Metabolisable energy (MJ/DM) 20·5 20·6 15·9
Fatty acid composition (wt %)
Myristic acid (C14:0) 6·3 0·4 0·8
Palmitic acid (C16:0) 14·7 6·1 13·2
Stearic acid (C18:0) 2·9 3·7 2·8
Oleic acid (C18:1cis-9) 14·3 22·5 20·6
Linoleic acid (C18:2n-6) 4·9 64·4 54·1
a Linolenic acid (C18:3n-3) 7·0 0·1 4·5
Arachidonic acid (C20:4n-6) 0·6 n.a. n.a.
Eicosapentaenoic acid (C20:5n-3) 12·3 0·2 0·2
Docosapentaenoic acid (C22:5n-
3)
2·1 0·01 0·05
Docosahexaenoic acid (C22:6n-3) 16·0 0 0·04
Σ n-3 FA 39·9 0·4 4·9
Σ n-6 FA 6·4 64·4 54·2
Fatty acid content is given in weight (wt) %; n.a. not analysed
DM-dry matter; PUFA-polyunsaturated fatty acids; FA-fatty acids; HFD-high fat
diet.
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primary antibody for 1 h at RT (insulin receptor b subu-
nit (IR b; Santa Cruz Biotechnology Inc, Santa Cruz, CA)
and phosphoinositol-3-kinase (PI3K; Upstate Biotechnol-
ogy, Lake Placid, NY) or overnight for PKC ζ (Santa Cruz
Biotechnology Inc). Specific antibodies were detected by
secondary antibodies conjugated to horse radish peroxi-
dase (1 h at RT; Sigma-Aldrich) and chemiluminescence
was used for protein visualisation (Pierce). Specific pro-
tein expression was quantified densitometrically using
Quantity One software (Bio-Rad). Intensity of signals
between different blots was compared by using one or
two reference samples on each blot.
Statistical analyses
For the statistical analyses of the of insulin signalling
parameters a One-Way Analysis of Variance (effect of
diet within lines) was used (SAS
© Systems, Release 8.2,
SAS Institute Inc., Cary, NC (SAS)). Protein expression
was determined for each mice line separately comparing
the different feeding groups. Statistical analysis for all the
other traits was performed using the least-squares
method and the GLM procedures of SAS. The following
model was employed for the analysis of variance with the
fix factors feeding (D) and selection (S): Yijk = μ+D i +
Pj +D i ×S j +E ijk (with μ = overall mean; Di = diet effect
(i = 3); Sj = effect of selection (j = 2); Di ×P j = Interaction
between diet and selection; Eijk = residual error). For the
following variables, plasma leptin, C18:2n-6, C20:5n-3,
C22:5n-3, C22:6n-3 and the ratio n-6/n-3 in liver and
C18:3n-3, C20:5n-3 and the ratio of n-6/n-3 in muscle
with different variances in diet groups, the SAS proc
mixed program was used to model these different var-
iances (by repeated statement and option group = diet).
All Tables and Figure 1 contain the least squares mean
(LSM) and the standard error (SE). All statistical tests
(Tukey-Kramer) of LSM were performed for a signifi-
cance level of p ≤ 0.05.
Results
The daily food intake was significantly different in the
selection lines and clearly influenced by the different
diets. Based on the long-term selection process described
above, the DU6 mice showed a rapid growth trajectory
during early postnatal life (overall difference in daily
weight gain DU6 versus DUhTP, factor genetic line p <
0.0001, factor diet p < 0.001, interaction p < 0.01; (mean
daily weight gain in g/d DU6-standard chow 1.04 ± 0.03,
n-3 HFD 1.21 ± 0.02, n-6 HFD 1.23 ± 0.02 (standard
chow versus HFD p < 0.001) DUhTP-standard chow
0.34 ± 0.01, n-3 HFD 0.40 ± 0.02, n-6 HFD 0.37 ± 0.01
(standard chow versus n-3 HFD p < 0.05)) and were
much heavier throughout the study (Table 2). Conse-
quently, the DU6 mice consumed twice the amount of
food than the DUhTP mice (Table 2). Feeding the HFD
diets led to a decrease in the total amount of food (in
grams) consumed in both mice lines compared to stan-
dard chow feeding. However, the relative amounts of
food consumed, adjusted for the metabolic body weight
(bwt
0.75) of the animals, was comparable between the
DU6 and DUhTP mice, there was no effect of selection
line. The daily calorie intake relative to bwt
0.75 further
revealed that all groups consumed very similar quantities
of energy with only slightly higher calorie intake in the
DUhTP mice fed the n-3 HFD (Table 2).
Lipid metabolism
Body fat deposition was influenced by selection line and
by the specific diet. The DU6 mice deposited significantly
more abdominal, perirenal and brown fat compared to
DUhTP animals (Table 2). Consequently, the body
weight at day 87 (end of the experiment) of DU6 mice
was significant higher than the body weight of DUhTP
mice in all feeding groups. Within the groups of DU6
mice, feeding either of the HFD resulted in a further
increase in the weight of abdominal, perirenal and brown
adipose tissues (Table 2). In contrast, feeding a HFD to
DUhTP mice did not result in significant changes in fat
deposition with abdominal adipose tissue weight reaching
a small trend towards increased levels (p = 0.06) in the n-
3 HFD-fed animals compared to the standard chow-fed
group (Table 2). Plasma leptin was measured as a blood
marker of total adiposity. The larger adipose tissue mass
in DU6 mice was reflected in leptin levels which were
much higher in DU6 animals than in DUhTP animals
(Table 3). Both HFD diets further increased plasma leptin
concentrations in the DU6 mice compared to DU6 fed
standard chow. The n-6 HFD had no effect on plasma
leptin concentration in DUhTP animals while n-3 HFD
increased plasma leptin concentrations slightly. Plasma
FFA levels were higher in DU6 mice but unaffected by
the HFD diets while total cholesterol was comparable in
both selection lines. However, n-3 HFD decreased the
cholesterol level significantly in DUhTP mice compared
to the chow diet and the n-6 HFD groups (Table 3). Fat
deposition in liver and muscle was not influenced by
selection line or by feeding HFD except in n-6 HFD-fed
DU6 mice, showing an increase in hepatic fat content
(Table 2). However, n-3 HFD increased liver weight in
both, DU6 and DUhTP (Table 2).
Glucose metabolism
Plasma glucose levels were similar in DU6 and DUhTP
mice fed with standard chow. However, in DU6 mice both
HFD diets increased glucose concentrations significantly.
This was accompanied by an increase in plasma insulin
but only in the DU6 mice fed on n-6 HFD. Insulin levels
of DUhTP mice were generally lower and not influenced
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lin signalling in liver and abdominal adipose tissue was
clearly influenced by HFD diets, but the effects differed in
both selection lines. Hepatic IRb expression was reduced
in both, the DU6 and DUhTP animals fed on n-3 HFD.
Furthermore, hepatic IRb expression was also reduced in
DUhTP animals fed on n-6 HFD but this reduction was
less pronounced than in DUhTP mice fed on n-3 HFD
(Figure 1). Hepatic p58 subunit of PI3K was increased
only in DU6 mice fed on n-6 HFD compared to DU6 fed
on n-3 HFD (160.3 ± 17.1 versus 90.5 ± 19.7, p < 0.001).
Hepatic PKC ζ was significantly reduced only in DU6
mice fed on n-3 HFD while adipose tissue PKC ζ was
reduced in DU6 mice fed on n-6 HFD. In DUhTP mice
fed n-3 HFD a dramatic increase of PKC ζ protein expres-
sion was observed in adipose tissue while the n-6 HFD
had no effect (Figure 1). In muscle (M. quadriceps
femoris), high-fat feeding did not influence expression
A. DU6  Hepatic IRȕ 
Control n-3 HFD n-6 HFD 0
2
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12 a
B. DUhTP  Hepatic IRȕ
Control n-3 HFD n-6 HFD 0
20 
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80 
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120
b
c
C. DU6 Hepatic PKC ȗ
Control n-3 HFD n-6 HFD 0
2
4
6
8
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b
a
D. DUhTP  Hepatic PKC ȗ 
Control n-3 HFD n-6 HFD 0
5
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0
5
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b
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25
a
b
a
E. DU6 Adipose tissue PKC ȗ F. DUhTP Adipose tissue PKC ȗ
Control n-3 HFD n-6 HFD Control n-3 HFD n-6 HFD
a
b
a
a
Figure 1 Effects of n-3 and n-6 high-fat diets on expression of insulin receptor b protein in liver (A, B) and protein kinase C ζ protein
in liver (C, D) and abdominal adipose tissue (E, F) in mice with distinct biologically traits, of an “energy storage phenotype“, the DU6
mice (high body weight line (A, C, E) and an “energy usage phenotype“, the DUhTP mice (high treadmill performance line) (B, D, F).
Trace quantity data are means ± SE, n = 10/group; lower case letter mark significant differences p < 0.05.
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(data not shown).
Lipids in liver
Analyses of liver lipids are shown in table 4. Differences
based on selection line were mainly observed in mice
fed n-6 HFD; there were fewer selection line effects with
the standard chow diet and no selection line effects with
n-3 HFD feeding. DU6 mice fed n-6 HFD synthesised
significantly more palmitic acid (C16:0) and less stearic
acid (C18:0) and arachidonic acid (C20:4n-6; AA) com-
pared to DUhTP mice. Furthermore, DU6 mice fed n-6
HFD or standard chow accumulated more oleic acid
(C18:1cis-9). As expected, n-3 HFD feeding of both
selection lines massively increased the amount of eicosa-
pentaenoic acid (C20:5n-3; EPA), docosapentaenoic acid
(C22:5n-3; DPA) and docosahexaenoic acid (C22:6n-3;
DHA) and resulted in a lower deposition of AA.
Comparable to observations in muscle tissue, there
were high amounts of myristic acid (C14:0) in liver of
both mice lines when fed n-3 HFD. Concentration of
oleic acid was lowest in DU6 mice fed n-3 HFD. Corre-
spondingly, the calculated Δ
9 desaturase (SCD) index
was low in DU6 mice fed n-3 HFD compared to stan-
dard chow and n-6 HFD fed mice. Interestingly, in
DUhTP mice fed standard chow, the SCD index was
lower compared to that in DU6 mice, indicating a differ-
ence determined by selection. However, the SCD index
was similar when DUhTP mice were fed n-3 and n-6
HFD, respectively. Accumulation of linoleic acid
(C18:2n-6; LA) and AA was highest in the liver of n-6
HFD-fed mice of both selection lines. Feeding n-6 HFD
Table 2 Effect of diet on body composition, daily food and energy intake of different mice lines
DU6 DUhTP
Standard chow n-3 HFD n-6 HFD Standard chow n-3 HFD n-6 HFD
LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE
Body weight (bwt) at 87
th day (g) 84·0 ± 1·6
a, A 96·2 ± 1·7
b, A 98·4 ± 1·5
b, A 28·.8 ± 1·6
a, B 35·4 ± 1·5
b, B 32·8 ± 1·6
B
Daily food intake (g/d) 11·4 ± 0·2
a, A 8·8 ± 0·2
b, A 8·8 ± 0·2
b, A 5·2 ± 0·2
a, B 4·8 ± 0·2
a, b, B 4·1 ± 0·2
b, B
Daily food intake
(g/bwt
0.75)
0·41 ± 0·02
a 0·29 ± 0·02
b 0·28 ± 0·02
b 0·42 ± 0·02
a 0·33 ± 0·02
b 0·30 ± 0·02
b
Daily calorie intake
(calorie/bwt
0.75)
1·24 ± 0·12 1·28 ± 0·12 1·24 ± 0·08 1·25 ± 0·28
a 1·49 ± 0·13
b 1·32 ± 0·05
a, b
Liver (g) 3·7 ± 0·1
a, A 4·1 ± 0·1
b, A 3·5 ± 0·1
a, A 1·1 ± 0·1
a, B 1·5 ± 0·1
b, B 1·2 ± 0·1
a, B
Abdominal fat (g) 2·6 ± 0·3
a, A 4·6 ± 0·3
b, A 5·2 ± 0·2
b, A 0·3 ± 0.3
B 1·0 ± 0.2
B 0·7 ± 0·3
B
Perirenal fat (g) 2·0 ± 0·2
a, A 3·4 ± 0·2
b, A 3·8 ± 0·2
b, A 0·2 ± 0·2
B 0·5 ± 0·2
B 0·4 ± 0·2
B
Brown fat (g) 0·20 ±
0·016
a, A
0·26 ±
0·017
b, A
0·25 ±
0·015
b, A
0·07 ±
0·016
B
0·13 ±
0·015
B
0·098 ±
0·016
B
Liver fat (%) 7.1 ± 0·9
a 8·0 ± 1·0
a, b 10·2 ± 0·9
b, A 6·7 ± 0·9 6·8 ± 0·9 8·7 ± 0·9
B
Muscle fat (%) 2·6 ± 0.2 3·5 ± 0·2 2·9 ± ·02 2·9 ± 0·2 3·1 ± 0·1 3·0 ± 0·2
DU6-mouse line selected for high body weight; DUhTP-mouse line selected for high treadmill performance
n-3 and n-6 HFD-high fat diet enriched with either n-3 or n-6 polyunsaturated fatty acids
LSM-Least square means of 8-10 mice per group, SE-Standard error, bwt-body weight, bwt
0.75- metabolic body weight
a, b-significant effect of diet at p ≤ 0.05 within the selected line
A, B -significant effect of selection line at p ≤ 0.05 within the feeding group.
Table 3 Effect of diet on blood parameter of different mice lines
DU6 DUhTP
Standard chow n-3 HFD n-6 HFD Standard chow n-3 HFD n-6 HFD
LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE
Leptin (ng/ml) 9·8 ± 3·1
a, A 27·9 ± 2·6
b, A 27·2 ± 5·5
b, A 0·8 ± 0·3
a, B 2·5 ± 0·6
b, B 1·1 ± 0·4
a, b, B
Cholesterol (mM) 4·7 ± 0·8 3·5 ± 0·9 5·2 ± 0·8 6·4 ± 0·9
a 4·0 ± 0·8
b 6·5 ± 0·8
a
FFA (mM) 1·2 ± 0·1
A 1·2 ± 0·1
A 1·4 ± 0·1
A 0·8 ± 0·1
B 0·5 ± 0·1
B 0·8 ± 0·1
B
Insulin (ng/ml) 1·38 ± 0·3
a, b, A 0·98 ± 0·3
a 1·81 ± 0·3
b, A 0·23 ± 0·3
B 0·21 ± 0·3 0·19 ± 0·3
B
Glucose (mM) 8·9 ± 0·8
a 11·0 ± 0·8
b, A 11·2 ± 0·8
b, A 8·9 ± 0·8 8·9 ± 0·8
B 7·9 ± 0·8
B
DU6-mouse line selected for high body weight; DUhTP-mouse line selected for high treadmill performance
n-3 and n-6 HFD-high fat diet enriched with either n-3 or n-6 polyunsaturated fatty acids
LSM-Least square means of 7-10 mice per group, SE-Standard error; FFA-free fatty acids;
a, b-significant effect of diet at p ≤ 0.05 within the selected line
A, B-significant effect of selection line at p ≤ 0.05 within the feeding group.
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Page 6 of 13increased the ratio of n-6/n-3 fatty acids in the liver fat
of both selection lines, and this effect was strongest in
DUhTP mice.
Lipids in quadriceps femoris muscle
The lipid concentrations of muscle tissue are presented in
table 5. The fatty acid composition of skeletal muscle
showed clear differences across the selection lines, but
these patterns were distinct to those found in liver. Intri-
guingly, the DUhTP mice fed standard chow showed
higher levels of DPA and DHA deposition in muscle com-
pared to the DU6 animals. Concentrations of saturated
fatty acids (SFA), monounsaturated fatty acids (MUFA),
a-linolenic acid (C18:3n-3; ALA) and EPA were increased
in muscle of DU6 mice compared to DUhTP mice when
fed n-3 HFD. The DU6 mice showed higher concentra-
tions of LA and AA when fed n-6 HFD resulting in a com-
parable n-6/n-3 ratio in both selection lines. The DU6
mice showed an increase in all SFA in muscle tissue in
response to n-3 HFD compared to n-6 HFD and standard
chow. This was not observed in DUhTP with the excep-
tion of the significant increase of myristic acid in both
mice lines. Other responses to n-3 and n-6 HFD were
quite similar between both selected lines. A summary of
the responses to the HFD in both selection lines is pre-
sented in table 6.
Discussion
The world-wide epidemic of obesity is due to complex,
multifactorial changes in lifestyle and environmental con-
ditions. In addition to an excess of calorie intake and com-
position of the diet, genetically determined pathways of
energy storage and utilisation contribute to the develop-
ment of obesity. The role of genetic factors in the patho-
genesis of obesity is undeniable with familial clusters
giving individuals in our modern “obesogenic” environ-
ment markedly different risks of becoming obese [21,22].
The present study investigates the fatty acid composition
of tissues and the metabolic responses to high-fat diets
rich in either n-3 or n-6 PUFA in mice, selected for high
Table 4 Effect of diet on fatty acid composition of liver of different mice lines
DU6 DUhTP
Standard chow n-3 HFD n-6 HFD Standard chow n-3 HFD n-6 HFD
LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE
SFA
+ 2420 ± 222 2794 ± 251 2981 ± 210 1889 ± 222 2520 ± 210 2224 ± 222
C14:0 23·2 ± 8
a 73·1 ± 9
b 41·2 ± 7
a, b 20·0 ± 8
a 77·7 ± 7
b 23·4 ± 8
a
C16:0 1888 ± 186 2057 ± 211 2292 ± 177
A 1335 ± 186 1721 ± 177 1351 ± 186
B
C18:0 435·3 ± 33 560·1 ± 38 547·5 ± 32
A 436·3 ± 33
a 589·5 ± 32
b 733·6 ± 33
c, B
MUFA
# 2074 ± 225
A 1567 ± 256 2544 ± 214
A 1006 ± 225
B 1473 ± 214 1547 ± 226
B
C16:1cis-9 218·4 ± 26 247·8 ± 29 143·5 ± 24 110·1 ± 26
a 244·6 ± 24
b 89·9 ± 25
a
C18:1cis-9 1636 ± 184
a, b, A 1178 ± 209
a 2225 ± 175
b, A 793 ± 185
B 1044 ± 175 1355 ± 185
B
∑n-6 FA
d 2706 ± 438
a 754·6 ± 497
b 6135 ± 416
c 2283 ± 438
a 759·7 ± 416
b 5876 ± 438
a
C18:2n-6 1941 ± 269
a 474·8 ± 47
b 5003 ± 575
c 1686 ± 349
a 478 ± 39
b 4605 ± 587
c
C20:4n-6 557·7 ± 38
a 226·8 ± 43
b 727·2 ± 37
cA 479·3 ± 39
a 236·9 ± 37
b 902·9 ± 39
cB
∑n-3 FA
e 505·0 ± 144
a 2385 ± 163
b 237·9 ± 136
a 556·6 ± 144
a 2197 ± 136
b 110·1 ± 144
a
C18:3n-3 70·4 ± 11
a 93·3 ± 13
a 13·3 ± 11
b 63·2 ± 11
a 85·1 ± 11
a 8·4 ± 2
b
C20:5n-3 15·6 ± 3
a 476·6 ± 64
b 10·0 ± 4
a 13·2 ± 3
a 400·9 ± 53
b 3·7 ± 4
a
C22:5n-3 22·2 ± 4
a 133·8 ± 20
b 11·3 ± 5
a 33·0 ± 4
a 114·0 ± 17
b 20·1 ± 6
a
C22:6n-3 387·6 ± 19
a 1634 ± 180
b 191·3 ± 32
a 439·3 ± 19
a 1556 ± 150
b 73·4 ± 34
a
PUFA 3219 ± 476
a 3144 ± 539
a 6404 ± 451
b 2844 ± 476
a 2962 ± 451
a 5999 ± 476
b
Δ9 Desaturase index
f 58·8 ± 2
a, A 34·4 ± 3
b 44·5 ± 2
c 27·0 ± 2
a, B 34·2 ± 2
a, b 39·3 ± 2
b
n-6/n-3 ratio 5·3 ± 0·3
a 0·3 ± 0·02
b 37·6 ± 6
c, A 4·0 ± 0·3
a 0·4 ± 0·02
b 52·3 ± 6
c, B
DU6-mouse line selected for high body weight; DUhTP-mouse line selected for high treadmill performance n-3 and n-6 HFD -high fat diet enriched with either n-
3o rn-6 polyunsaturated fatty acids
LSM-Least square means, SE-standard error, fatty acid concentrations in mg/100 g fresh tissue;
MUFA-monounsaturated fatty acids; SFA-saturated fatty acids; PUFA-polyunsaturated fatty acids; FA-fatty acids;
a, b, c-significant effect of diet at p ≤ 0.05 within the selected line
A, B-significant effect of selection line at p ≤ 0.05 within the feeding group
+ Sum of saturated fatty acids (C10:0+C11:0+C12:0+C13:0+C14:0+C15:0+C16:0+C17:0+C18:0+C20:0+C21:0+C22:0+C23:0+ C24:0)
# Sum of MUFA (C14:1+C16:1+C17:1+∑ C18:1 trans isomers+C18:1cis-9+C18:1cis-11+C22:1+C24:1)
d Sum of n-6 fatty acids (C18:3n-6+ C22:4n-6+ C20:3n-6+ C18:2n-6+ C20:4n-6)
e Sum of n-3 fatty acids (C20:3n-3+ C22:6n-3+ C22:5n-3+ C20:5n-3+ C18:4n-3+ C18:3n-3)
f Δ9 Desaturase index = ((C14:1+C16:1+C18:1+C17:1)/(C14:1+C16:1+C18:1+C17:1+C14:0+C16:0+C17:0+ C18:0))*100.
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Page 7 of 13body weight (DU6), leading to rapid obesity development,
or selected for high treadmill performance, leading to a
lean phenotype. This study also investigates whether dif-
ferent metabolic responses may be linked to changes in
insulin signalling pathways in liver, muscle and adipose tis-
sue. The mouse lines used in the present study reflect the
range of genetic predisposition to obesity development
commonly observed under physiological conditions [26].
It is most likely that selection of these mouse lines pro-
duced metabolic phenotypes by polygenic variants of
genes as described in human populations [33]. The mice
lines used in this study reveal distinct metabolic pheno-
types. The DU6 mice display an “energy storage phenotype”
that is characterised by high body weight, increased food
intake, larger fat depots, higher liver weight and higher
plasma FFA, leptin and insulin levels. In contrast, the
DUhTP mice display an “energy usage phenotype” that is
characterised by lower body weight, less food intake, smal-
ler fat depots, lower liver weight and lower plasma FFA,
leptin and insulin levels. The findings of the present study
also suggest that there is a strong genetic contribution to
the pattern of fatty acid composition of body tissues. The
selection lines showed clear differences in the fatty acid
composition of liver and muscle even under standard
chow feeding conditions. These data are supported by stu-
dies in pigs which showed a significant heritability of fatty
acid composition in muscle, especially for the concentra-
tions of n-3 and n-6 PUFA [34]. Interestingly, in liver, the
amount of oleic acid was lower in DUhTP mice in com-
parison with DU6 mice which may be related to the
reduced capacity to synthesise oleic acid from stearic acid
as indicated by the decrease in delta-9 desaturase index. In
muscle, palmitoleic acid content was also lower in
DUhTP. This difference in the SCD index between selec-
tion lines appears to have a genetic origin. Furthermore
the capacity for the de novo synthesis of long-chain n-3
PUFA, DHA and DPA, in muscle was elevated in DUhTP
mice fed standard chow compared to DU6 mice. This may
lead to increased insulin sensitivity, an association which
has been previously observed in human skeletal muscle
Table 5 Effect of diet on fatty acid composition of quadriceps femoris muscle of different mice line
DU6 DUhTP
Standard chow n-3 HFD n-6 HFD Standard chow n-3 HFD n-6 HFD
LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE LSM ± SE
SFA
+ 365·5 ± 45
a 697·2 ± 48
b, A 376·6 ± 43
a 327·0 ± 45 325·1 ± 43
B 218·2 ± 45
C14:0 11·21 ± 4
a 62·31 ± 4
b, A 9·58 ± 4
a 6·5 ± 4
a 24·1 ± 4
b, B 3·9 ± 4
a
C16:0 265·9 ± 34
a 488·5 ± 36
b, A 248·4 ± 32
a 199·3 ± 34 210·0 ± 32
B 120·2 ± 34
C18:0 62·4 ± 6
a 98·4 ± 6
bA 91·2 ± 6
a, b 85·2 ± 6
a 57·7 ± 6
bB 68·9 ± 6
a, b
MUFA
# 225·6 ± 50
a 568·2 ± 53
b, A 375·7 ± 47 180·0 ± 50 280·7 ± 47
B 183·1 ± 50
C16:1cis-9 70·4 ± 10
a, b, A 96·6 ± 10
a, A 36·7 ± 9
b 25·4 ± 10
B 41·6 ± 9
B 14·1 ± 10
C18:1cis-9 206·7 ± 33 320·8 ± 35
A 296·4 ± 31
A 116·8 ± 33 149·5 ± 31
B 145·8 ± 33
B
∑n-6 FA
d 345·0 ± 44
a 141·6 ± 47
b 800·6 ± 42
cA 302·5 ± 44
a 70·6 ± 42
b 445·0 ± 44
a, B
C18:2n-6 225·6 ± 42
a 100·9 ± 44
a 653·3 ± 40
bA 167·5 ± 42
a, B 43·2 ± 40
a 318·7 ± 42
bB
C20:4n-6 98·2 ± 5
a 25·4 ± 5
b 112·7 ± 5
a, A 108·4 ± 5
a 20·4 ± 5
b 91·2 ± 5
aB
∑n-3 FA
e 99·5 ± 12
a, A 325·0 ± 13
b, A 37·9 ± 12
c 171·8 ± 12
a, B 270·6 ± 12
b, B 25·7 ± 12
c
C18:3n-3 9·4 ± 1·6
a 48·0 ± 5
b, A 2·3 ± 0·3
a 5·7 ± 1·6 6·8 ± 5
B 1·3 ± 0·4
C20:5n-3 0·9 ± 0·1
a 50·5 ± 0·5
b, A 1·0 ± 0·2
a, A 1·3 ± 0·1
a 26·4 ± 4
bB 0·1 ± 0·2
c, B
C22:5n-3 7·9 ± 1
a, A 23·1 ± 1
b 3·1 ± 1
a 22·3 ± 1
a, B 20·5 ± 1
a 2·7 ± 1
b
C22:6n-3 80·6 ± 9
a, A 201·2 ± 9
b 30·7 ± 8
c 142·1 ± 8
a, B 215·6 ± 8
b 21·3 ± 9
c
PUFA 445·2 ± 50
a 468·8 ± 53
a 839·6 ± 48
b, A 475·0 ± 50 342·0 ± 47 471·7 ± 50
B
Δ9 Desaturase
index
f
43·4 ± 2
a, b 41·2 ± 2
a 48·5 ± 2
b, A 33·7 ± 2
a 42·5 ± 2
b 45·0 ± 2
b, B
n-6/n-3 ratio 3·4 ± 0·2
a, A 0·40 ± 0·02
b, A 23·8 ± 2·6
c 1·9 ± 0·2
a, B 0·3 ± 0·02
b, B 17·6 ± 2·8
c
DU6-mouse line selected for high body weight; DUhTP-mouse line selected for high treadmill performance
n-3 and n-6 HFD-high fat diet enriched with either n-3 or n-6 polyunsaturated fatty acids
LSM-Least square means, SE-Standard error, fatty acid concentrations in mg/100 g fresh tissue;
MUFA-monounsaturated fatty acids; SFA-saturated fatty acids; PUFA-polyunsaturated fatty acids; FA-fatty acids;
a, b, c-significant effect of diet at p ≤ 0.05 within the selected line,
A, B -significant effect of selection line at p ≤ 0.05 within the feeding group; all interaction DxL were significant at p ≤ 0.05;
+ Sum of saturated fatty acids: (C10:0+C11:0+C12:0+C13:0+C14:0+C15:0+C16:0+C17:0+C18:0+C20:0+C21:0+C22:0+C23:0+ C24:0)
# Sum of MUFA (C14:1+C16:1+C17:1+∑ C18:1 trans isomers+C18:1cis-9+C18:1cis-11+C22:1+C24:1)
d Sum of n-6 FA (C18:3n-6+ C22:4n-6+ C20:3n-6+ C18:2n-6+ C20:4n-6)
e Sum of n-3 FA (C20:3n-3+ C22:6n-3+ C22:5n-3+ C20:5n-3+ C18:4n-3+ C18:3n-3)
f Δ9 Desaturase index = ((C14:1+C16:1+C18:1+C17:1)/(C14:1+C16:1+C18:1+C17:1+C14:0+C16:0+C17:0+ C18:0))*100.
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Page 8 of 13containing increased proportions of PUFA with twenty
and twenty-two carbons [35]. Increased n-3 PUFA content
in muscle cells was identified as a key driver of inner mito-
chondrial membrane properties, thereby affecting mem-
brane-associated proteins [36]. Carnitine palmitoyl-
transferase activity was increased by dietary n-3 PUFA
suggesting an enhanced lipolytic capacity in skeletal mus-
cle and enhanced mitochondrial membrane fluidity [37]. It
is therefore tempting to speculate that the increased n-3
PUFA concentrations in muscle may contribute to a meta-
bolic status in DUhTP that leads to the energy usage phe-
notype and to the ability to adapt more successfully to a
HFD. In contrast, DU6 mice have significantly less long-
chain n-3 PUFA concentrations in muscle, they have
lower insulin signalling capacity (unpublished results) and
probably less oxidative capacity to burn fatty acids in ske-
letal muscle resulting in the energy storage phenotype.
Different responses to n-3 HFD or n-6 HFD
The mechanisms underlying diet-induced obesity are still
not fully understood, but are influenced by a range of
genetic factors [38]. The present study investigated meta-
bolic responses to isocaloric high-fat diets enriched with
either n-3 PUFA or n-6 PUFA in two long-term selected
lines of mice. The metabolic responses of the animals
were defined by measuring key markers of lipid and glu-
cose metabolism in plasma, liver, muscle and adipose tis-
sue and by determining fatty acid composition of liver
and muscle. In agreement with many previous studies,
fatty acid composition of body tissues was mainly deter-
mined by dietary fat intake in both lines of mice. [39,40].
However, the specific metabolic responses in body tissues
to a HFD enriched with n-3 or n-6 PUFA differed mark-
edly between the two selection lines. Major effects are
discussed below, separately, for lipid and glucose metabo-
lism. Different responses to HFD occurred despite similar
calorie intake per bwt
0.75 between the feeding groups and
between the selection lines. Thus, our data suggest that
mice with a predisposition for obesity development, the
energy storage phenotype, or to leanness, the energy usage
phenotype, respond differently to isocaloric HFD rich in
n-3 PUFA or n-6 PUFA. However, the formulation of the
diets used in the present study had two limitations.
Firstly, differences in protein content of the control diet
and the high-fat diets could have potentially influenced
some metabolic processes. Secondly, the higher content
of myristic acid in n-3 HFD may have modified some of
the biological effects. Although unlikely, the magnitude
Table 6 Summary of major effects of n-3 and n-6 HFD on lipid and glucose metabolism
DU6 DUhTP DU6 DUhTP
Lipid
metabolism
n-3 HFD n-6 HFD n-3 HFD n-6 HFD Glucose
metabolism
n-3 HFD n-6 HFD n-3 HFD n-6 HFD
Leptin ↑↑↑- Insulin - (↑)- -
FFA - - - - Glucose ↑↑--
Cholesterol - - ↓ - Liver IRb ↓ - ↓↓
Fat deposition ↑↑ (↑) - Liver PI3K - - - -
Body weight ↑↑↑- Liver PKCζ ↓ ---
Liver weight ↑ - ↑ - Muscle IRb ----
Liver fat - ↑ - - Muscle PKCζ ----
Muscle PI3K - - - -
Adipose PKCζ - ↓↑-
Fatty acid composition
liver
Fatty acid composition
muscle
SFA - - - - SFA ↑ ---
Myristic acid ↑ - ↑ - Myristic acid ↑ - ↑ -
Palmitic acid - - - - Palmitic acid ↑ ---
Stearic acid - - ↑↑ Stearic acid ↑ - ↓ -
Oleic acid - (↑) - - Oleic acid - - - -
MUFA - - - - MUFA ↑ ---
PUFA - ↑ - ↑ PUFA - ↑ --
n-3 PUFA ↑ - ↑ - n-3 PUFA ↑↓↑↓
n-6 PUFA ↓↑↓- n-6 PUFA ↓↑↓-
DU6-mouse line selected for high body weight; DUhTP-mouse line selected for high treadmill performance
n-3 and n-6 HFD-high fat diet enriched with either n-3 or n-6 polyunsaturated fatty acids
FFA-free fatty acids; IR b-Insulin receptor b subunit; PI3K-phosphatidyl inositol-3 kinase; PKC ζ-atypical protein kinase ζ; PUFA-polyunsaturated fatty acids; MUFA-
monounsaturated fatty acids
- no change; ↑ increase compared to respective standard chow fed group; ↓ decrease compared to respective standard chow group; (↓)(↑) tendency to decrease/
increase.
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Page 9 of 13of such potential influences could not be addressed in the
present study.
Lipid metabolism
One of the most important contributing factors to obesity
development is the increased consumption of energy-
dense foods resulting in higher calorie intake and higher
intake of dietary fat [41]. Interestingly, only the DU6 mice
showed a significant increase in adipose tissue weight in
response to both the n-3 HFD and the n-6 HFD. Body
weight increased significantly in DU6 mice fed either n-3
or n-6 HFD due to the high calorie density of these diets,
although food intake measured in grams was reduced. The
higher body weight of DU6 mice was mainly due to
increased fat deposition, emphasising the energy storage
phenotype of these animals. The effects of the HFD on
parameters of adiposity were almost missing in DUhTP
mice. Interestingly, the increase in adiposity in DU6 mice
was not caused by changes in food intake; the calorie
intake per bwt
0.75 was very similar between the different
selection lines. These data clearly underscore the biologi-
cal importance of genetically determined pathways of
energy utilisation that contribute to the development of
obesity.
Many dietary components and metabolic conditions
are known to be involved in nutrient partitioning that
shift energy from storage in adipose tissues to energy
utilisation in muscle and to muscle protein synthesis
[42-45]. A lower capacity to oxidise fat in skeletal mus-
cle and liver in high fat feeding conditions was stipu-
lated as the main driver of shifting energy into storage
as fat in obesity-prone rats [44]. Data from the present
study suggest that dietary n-3 and n-6 PUFA may play a
role in nutrient partitioning. The DUhTP mice fed a
HFD showed a remarkable adaptive response. Although
body weight was increased in the n-3 HFD group, total
cholesterol levels were decreased when DUhTP mice
were fed n-3 HFD, indicating a health benefit on lipid
metabolism of the n-3 PUFA diet by inhibiting choles-
terol synthesis [46]. In addition, in DUhTP there was
only a trend of an increase in adipose tissue weights and
a slight, but significant increase in plasma leptin concen-
trations when fed n-3 HFD, conveying further health
benefits on lipid metabolism. These intriguing findings
warrant further study and may involve n-3 PUFA-
mediated changes in peripheral oxidation of fatty acids,
especially in individuals with an energy usage phenotype
[37,47,48].
Glucose metabolism
The main differences in glucose metabolism responses to
n-3 HFD and n-6 HFD for the two selection lines are
described by the following main findings. Plasma glucose
concentrations were increased by both HFD in DU6
mice. In addition, plasma insulin concentrations in DU6
fed n-6 HFD were increased suggesting development of
insulin resistance [49]. In contrast, HFD-induced hyper-
glycaemia and hyperinsulinaemia was absent in DUhTP
mice. Interestingly, in both selection lines n-3 HFD
reduced hepatic protein expression of a key component
of the insulin signalling pathway, the b-subunit of the IR
b,w h i l et h eP K Cζ signalling protein concentration was
reduced in liver tissue of DU6 mice only. In contrast, in
abdominal adipose tissue, the PKC ζ protein expression
was strongly increased by n-3 HFD indicating a higher
capacity for glucose uptake. Importantly, this effect was
only observed in DUhTP mice. In previous studies it was
suggested that the adipose tissue is a key player in modu-
lating insulin-sensitising effects of dietary n-3 PUFA
[50,51]. Although the underlying molecular pathways are
still uncertain, our data suggest that up-regulation of
PKC ζ within the insulin signalling cascade by dietary n-3
PUFA may explain the insulin-sensitising effects. The
present study showed for the first time that PKC ζ may
b eat a r g e to fn-3 PUFA action in a tissue-specific man-
ner. It is increasingly appreciated that the insulin-sensi-
tising effects in adipocytes may be crucial for the health
benefits of dietary n-3 PUFA [36].
Interestingly, PKC ζ expression was unchanged in adi-
pose tissue when DU6 mice were fed n-3 HFD, but hepatic
insulin signalling parameters decreased. Consequently,
plasma glucose concentrations increased but without any
changes in insulin concentration. It is intriguing that mus-
cle tissue did not respond to the HFD in either of the
selection lines suggesting that skeletal muscle may be less
responsive to dietary regulating of insulin sensitivity in
mice fed HFD. Comparable results were obtained in a
study using C57BL/6J mice after an eight-week HFD
showing only minor changes in muscular transcriptome
[52]. The increase in PKC ζ expression in adipose tissue
and the decrease in liver insulin signalling in DUhTP mice
offers novel pathways for cellular mechanism of glucose
partitioning in response to increased dietary n-3 PUFA.
This shift in glucose re-partitioning may also be induced
in DU6 mice fed n-3 HFD; however, any effect will be less
efficient due to the lack of increased PKC ζ expression in
adipose tissue. This notion is supported by our observa-
tion of increased plasma glucose concentrations with n-3
HFD in DU6 mice. HFD enriched with n-6 PUFA led to
hyperglycaemia and hyperinsulinaemia in DU6 mice indi-
cating insulin resistance which is commonly induced by
HFD feeding [49]. The observed decrease in PKC ζ expres-
sion in adipose tissue may contribute to development of
insulin resistance in the energy storage phenotype,a g a i n ,
demonstrating the important metabolic role of adipose tis-
sue in the regulation of insulin sensitivity. In contrast,
DUhTP mice showed only small shifts in hepatic insulin
signalling when fed with n-6 HFD which was paralleled by
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mal physiological range. The data suggest that the capacity
to deposit glucose in insulin-sensitive adipose tissue and
liver was maintained in the energy usage phenotype even in
the face of a n-6 HFD.
Fatty acid composition
The n-3 and n-6 HFD resulted in different fatty acid
composition of liver and muscle in DU6 and DUhTP
mice. These changes in fatty acid composition reflect
the fatty acid composition of the diet which has been
demonstrated previously in studies by Valencak and Ruf
[19] and Poureslami et al. [53]. Diet-induced changes
were observed in the content of myristic acid which is
increased in both, muscle and liver of each line fed n-3
HFD reflecting the high myristic acid content of this
diet. Similarly, the increase in n-3 PUFA concentrations
with a simultaneous decrease of n-6 PUFA concentra-
tions in muscle and liver with n-3 HFD feeding was
observed in both lines of mice indicating a dominant
influence of the dietary fat content. However, some dif-
ferences seemed to be set by long-term selection of the
mice lines indicating a high heritability of fatty acid
composition in some tissues. The heritability of body
tissues fatty acid composition, especially the deposition
of n-3 PUFA, has been widely studied in many species,
including pigs, salmon and humans [34,54,55]. In
DUhTP mice deposition of ALA and EPA was lower in
muscle resulting in a smaller sum of n-3 PUFA when
the n-3 HFD was fed. The lower content of n-3 PUFA
in muscle, most likely located in cell and mitochondrial
membranes, suggests a lower susceptibility to peroxida-
tion compared to DU6 [56], thereby contributing to
muscle cell viability and performance in DUhTP. It is
tempting to speculate that an increase in the antioxidant
capacity in DUhTP mice may also lower susceptibility to
peroxidation, thus providing further health benefits of
dietary n-3 PUFA [57]. This may contribute to the
increased running performance in DUhTP mice and
support the energy usage phenotype.A ni n c r e a s ei nt h e
n-6 PUFA content of body tissues was expected with n-
6 HFD feeding, however, this was only observed in DU6
liver and muscle and not in the DUhTP animals indicat-
ing again a genetic component of fatty acid deposition.
Another remarkable difference in specific fatty acid
deposition in muscle was observed regarding the SFA
content, especially palmitic and stearic acid. Feeding n-3
HFD increased the content of these SFA in DU6 but
not in DUhTP mice. These results may suggest that
lipogenic pathways are amplified in the DU6 line
because palmitic acid is the end product of de novo fatty
acid synthesis. Enhanced capacity for lipogenesis, even
when HFD are fed, may contribute to the development
of the energy storage phenotype of the DU6 mice.
Summary
Data presented in this paper advance our understanding
about the interactions between genetic predisposition
and environmental influences in the development of obe-
sity and its metabolic complications. Mice from long-
term selection experiments served as models to examine
the contributions of genetic factors in determining speci-
fic dietary influences on metabolic regulation relevant to
obesity development. Mice lines with distinct biological
traits, of an “energy storage phenotype“, the DU6 mice;
and of an “energy usage phenotype“, the DUhTP mice
served to investigate whether different genetic predisposi-
tions for obesity or leanness may favour specific meta-
bolic pathways and down-stream effects of lipid or
carbohydrate metabolism. The specific metabolic
responses in body tissues to a HFD enriched with n-3 or
n-6 PUFA differed markedly between the two selection
lines despite similar calorie intake per bwt
0.75 between
the selection lines. In DUhTP mice, the effects of the
HFD on parameters of adiposity such as large fat pads,
high plasma cholesterol, triglyceride, glucose and insulin
concentrations were almost missing, drawing attention to
the biological importance of genetically determined path-
ways that contribute to the development of obesity. The
results of the present study a l s os u g g e s tt h a td i e t a r yn-3
PUFA may play an important role in nutrient partition-
ing. Metabolic health benefits of dietary n-3 PUFA may
be explained, at least in part, by changes in insulin action
and lipid metabolism through re-partitioning of energy
from liver and muscle to adipose tissue. The present
study showed for the first time that PKC ζ within the
insulin signalling cascade may be a target of dietary n-3
PUFA action in a tissue-specific manner. The up-regula-
tion of PKC ζ in adipose tissue may explain the insulin-
sensitising effects of dietary n-3 PUFA. However, impor-
tant genotype-diet interactions may explain why such
diets may have modest effects in some population groups.
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